Biocompatibility of nanomaterials and their immunological properties

TR Kyriakides, A Raj, TH Tseng, H Xiao… - Biomedical …, 2021 - iopscience.iop.org
Nanomaterials (NMs) have revolutionized multiple aspects of medicine by enabling novel
sensing, diagnostic, and therapeutic approaches. Advancements in processing and …

Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm

N Song, H Wakimoto, F Rossignoli, D Bhere… - Stem Cells, 2021 - academic.oup.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has grown to be a global
public health crisis with no safe and effective treatments available yet. Recent findings …

Mesenchymal stem cells: A living carrier for active tumor-targeted delivery

T Zhang, R Lin, H Wu, X Jiang, J Gao - Advanced Drug Delivery Reviews, 2022 - Elsevier
The strategy of using mesenchymal stem cells (MSCs) as a living carrier for active delivery of
therapeutic agents targeting tumor sites has been attempted in a wide range of studies to …

Exosomes overexpressing miR-34c inhibit malignant behavior and reverse the radioresistance of nasopharyngeal carcinoma

FZ Wan, KH Chen, YC Sun, XC Chen, RB Liang… - Journal of translational …, 2020 - Springer
Background Malignant behavior and radioresistance, which severely limits the efficacy of
radiation therapy (RT) in nasopharyngeal carcinoma (NPC), are associated with tumor …

Chemotherapeutic drugs-induced pyroptosis mediated by gasdermin E promotes the progression and chemoresistance of pancreatic cancer

S Li, M Yue, H Xu, X Zhang, T Mao, M Quan, J Ma… - Cancer Letters, 2023 - Elsevier
Pyroptosis is closely associated with cancer development; however, the role of pyroptosis in
pancreatic ductal adenocarcinoma (PDAC), a fatal malignant tumour with a poor overall …

The dual role of mesenchymal stem cells in cancer pathophysiology: pro-tumorigenic effects versus therapeutic potential

Y Slama, F Ah-Pine, M Khettab, A Arcambal… - International Journal of …, 2023 - mdpi.com
Mesenchymal stem/stromal cells (MSCs) are multipotent cells involved in numerous
physiological events, including organogenesis, the maintenance of tissue homeostasis …

Engineered sTRAIL-armed MSCs overcome STING deficiency to enhance the therapeutic efficacy of radiotherapy for immune checkpoint blockade

KCY Huang, SF Chiang, HY Chang, WTL Chen… - Cell Death & …, 2022 - nature.com
Radiotherapy (RT) mainly elicits antitumor immunity via the cGAS/STING axis for type I
interferon (IFN) production. However, dysregulation of cGAS/STING constrains radiotherapy …

TRAIL-based gene delivery and therapeutic strategies

H Zhong, H Wang, J Li, Y Huang - Acta Pharmacologica Sinica, 2019 - nature.com
TRAIL (tumor necrosis factor-related apoptosis-inducing ligand), also known as APO2L,
belongs to the tumor necrosis factor family. By binding to the death receptor 4 (DR4) or DR5 …

TRAIL in oncology: From recombinant TRAIL to nano-and self-targeted TRAIL-based therapies

H Dianat-Moghadam, M Heidarifard, A Mahari… - Pharmacological …, 2020 - Elsevier
TNF-related apoptosis-inducing ligand (TRAIL) selectively induces the apoptosis pathway in
tumor cells leading to tumor cell death. Because TRAIL induction can kill tumor cells, cancer …

[PDF][PDF] RETRACTED: Mesenchymal Stem/Stromal Cells as a Vehicle for Cytokine Delivery: An Emerging Approach for Tumor Immunotherapy

E Razeghian, R Margiana, S Chupradit… - Frontiers in …, 2021 - frontiersin.org
Pro-inflammatory cytokines can effectively be used for tumor immunotherapy, affecting every
step of the tumor immunity cycle. Thereby, they can restore antigen priming, improve the …